Acurian, Inc. Expands its Market Leading Position in the Direct-to-Patient Arena; Clinical Trial Recruitment Database Now Over 70 Million and Growing

HORSHAM, Pa.--(BUSINESS WIRE)--Acurian, Inc., a leading, full-service provider of global patient enrollment and retention solutions, announced today that it has expanded its market-leading, opted-in database to over 70 million people. These are individuals who have self-reported specific ailments and provided permission to be contacted exclusively by Acurian for clinical trial opportunities.